Aceragen Inc | IDRA - Pre Tax Profit

Idera Pharmaceuticals reported $9.14M in Pre-Tax Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Pre Tax Profit Change
Abbott ABT:US USD 2.17B 316M
Agenus AGEN:US USD -74102000 17.39M
Alnylam Pharmaceuticals ALNY:US USD -207021000 122.34M
Amgen AMGN:US USD 2.54B 364M
Biomarin Pharmaceutical BMRN:US USD -17558000 15.65M
Dynavax Technologies DVAX:US USD 67.97M 3.88M
Eli Lilly And LLY:US USD 2.04B 38.3M
Gilead Sciences GILD:US USD 2.52B 357M
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Idera Pharmaceuticals IDRA:US USD 9.14M 14.44M
Merk MRK:US USD 4.89B 560M
Mirati Therapeutics MRTX:US USD -202221000 28.91M
Nektar Therapeutics NKTR:US USD -56544000 2.66M
Pfizer PFE:US USD 7.38B 3.3B
Roche Holding ROG:VX 8.85B 3.26B
Sarepta Therapeutics SRPT:US USD -101306000 155.11M
Ultragenyx Pharmaceutical RARE:US USD -153284000 85.54M